Stay updated on Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.

Latest updates to the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page
- Check7 days agoChange DetectedAn NIH funding reference for 2017 was added to the study's identifier section, reflecting the funding source associated with the trial. This is an administrative detail that does not alter the study design, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, signaling a new minor update to the page. This reflects a metadata or formatting adjustment rather than changes to study details.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling an administrative update to the record. No study details or data appear to be affected by this change.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page footer now displays Revision: v3.6.3, replacing the previous v3.6.2. This reflects a minor update to the page template and does not affect study content.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing Revision: v3.6.0, indicating an updated revision of the page’s documents.SummaryDifference0.1%

- Check78 days agoChange DetectedEnrollment status updated to indicate recruitment is closed. New study-navigation sections and a formatting/version update provide clearer guidance on reading the study record and joining the study.SummaryDifference0.4%

Stay in the know with updates to Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.